QuidelOrtho Corp (QDEL) stock
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.57−0.30 (-3.04%)
Close on Nov 18, 2026Market cap $656.27MP/E –Yield –
QuidelOrtho market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
QuidelOrtho's market cap was $817.03M on Nov 11, 2026, against $1.86B a year earlier. Over the last 5 years it ranged from $719.88M to $6.02B, with a median of $2.99B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $817.03M | -57.9% |
| 2025 | Dec 31, 2025 | $1.94B | -35.2% |
| 2024 | Dec 31, 2024 | $2.99B | -39.2% |
| 2023 | Dec 29, 2023 | $4.92B | -12.9% |
| 2022 | Dec 30, 2022 | $5.65B | -3.9% |
| 2021 | Dec 31, 2021 | $5.89B | – |
See a number that looks wrong?